Way100635-induced Augmentation of the 5-HT-elevating Action of Citalopram: Relative Importance of the Dose of the 5-HT1A (Auto)receptor Blocker Versus that of the 5-HT Reuptake Inhibitor

This publication has 28 references indexed in Scilit:

• Effect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat Brain
  Neuropsychopharmacology, 1996
• (−)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine
  European Journal of Pharmacology, 1996
• A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635
  European Journal of Pharmacology, 1995
• Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation
  Synapse, 1995
• Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression
  Journal of Clinical Psychopharmacology, 1995
• Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration
  Neuropharmacology, 1995
• Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis
  Life Sciences, 1994
• Serotonin 5‐HT_1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis Study
  Journal of Neurochemistry, 1993
• Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex
  Brain Research, 1992
• The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus
  European Journal of Pharmacology, 1992